FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367627100> ?p ?o ?g. }

• W4367627100 endingPage "739" @default.
• W4367627100 startingPage "739" @default.
• W4367627100 abstract "Patients undergoing bone fractures frequently suffer from irritating chronic pain after orthopedic repairs. Chemokine-mediated interactions between neurons and microglia are important steps for neuroinflammation and excitatory synaptic plasticity during the spinal transmission of pathological pain. Recently, glabridin, the main bioactive component of licorice, has been shown to exhibit anti-nociceptive and neuroprotective properties for inflammatory pain. This present study evaluated the therapeutic potential of glabridin and its analgesic mechanisms using a mouse model of tibial fracture-associated chronic pain. Repetitive injections of glabridin were delivered spinally daily for 4 continuous days from days 3 to 6 after the fractures. Herein, we discovered that repeated administrations of glabridin (10 and 50 μg, but not 1 μg) could prevent prolonged cold allodynia and mechanical allodynia following bone fractures. A single intrathecal intervention with glabridin (50 μg) relieved an existing chronic allodynia two weeks following the fracture surgeries. Systemic therapies with glabridin (intraperitoneal; 50 mg kg−1) were protective against long-lasting allodynia caused by fractures. Furthermore, glabridin restricted the fracture-caused spinal overexpressions of the chemokine fractalkine and its receptor CX3CR1, as well as the elevated number of microglial cells and dendritic spines. Strikingly, glabridin induced the inhibition of pain behaviors, microgliosis, and spine generation, which were abolished with the co-administration of exogenous fractalkine. Meanwhile, the exogenous fractalkine-evoked acute pain was compensated after microglia inhibition. Additionally, spinal neutralization of fractalkine/CX3CR1 signaling alleviated the intensity of postoperative allodynia after tibial fractures. These key findings identify that glabridin therapies confer protection against inducing and sustaining fracture-elicited chronic allodynia by suppressing fractalkine/CX3CR1-dependent spinal microgliosis and spine morphogenesis, suggesting that glabridin is a promising candidate in the translational development of chronic fracture pain control." @default.
• W4367627100 created "2023-05-02" @default.
• W4367627100 creator A5000128145 @default.
• W4367627100 creator A5010330339 @default.
• W4367627100 creator A5015296994 @default.
• W4367627100 creator A5042990707 @default.
• W4367627100 creator A5072372429 @default.
• W4367627100 date "2023-04-29" @default.
• W4367627100 modified "2023-09-27" @default.
• W4367627100 title "Glabridin Therapy Reduces Chronic Allodynia, Spinal Microgliosis, and Dendritic Spine Generation by Inhibiting Fractalkine-CX3CR1 Signaling in a Mouse Model of Tibial Fractures" @default.
• W4367627100 cites W1966695391 @default.
• W4367627100 cites W2038652772 @default.
• W4367627100 cites W2076649598 @default.
• W4367627100 cites W2512579337 @default.
• W4367627100 cites W2520478369 @default.
• W4367627100 cites W2521532521 @default.
• W4367627100 cites W2531309662 @default.
• W4367627100 cites W2551668281 @default.
• W4367627100 cites W2624748413 @default.
• W4367627100 cites W2726408731 @default.
• W4367627100 cites W2786697307 @default.
• W4367627100 cites W2789753545 @default.
• W4367627100 cites W2904185271 @default.
• W4367627100 cites W2922032042 @default.
• W4367627100 cites W2940404939 @default.
• W4367627100 cites W2946154356 @default.
• W4367627100 cites W2947866582 @default.
• W4367627100 cites W2961161544 @default.
• W4367627100 cites W2967133259 @default.
• W4367627100 cites W3009515831 @default.
• W4367627100 cites W3041720930 @default.
• W4367627100 cites W3044953744 @default.
• W4367627100 cites W3080230568 @default.
• W4367627100 cites W3091321512 @default.
• W4367627100 cites W3113472562 @default.
• W4367627100 cites W3120077678 @default.
• W4367627100 cites W3129801476 @default.
• W4367627100 cites W3132904281 @default.
• W4367627100 cites W3164946267 @default.
• W4367627100 cites W3179391229 @default.
• W4367627100 cites W3182408101 @default.
• W4367627100 cites W4207034494 @default.
• W4367627100 cites W4281620627 @default.
• W4367627100 cites W4289833680 @default.
• W4367627100 cites W4292014102 @default.
• W4367627100 cites W4292466653 @default.
• W4367627100 cites W4310086145 @default.
• W4367627100 cites W4313855221 @default.
• W4367627100 doi "https://doi.org/10.3390/brainsci13050739" @default.
• W4367627100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37239211" @default.
• W4367627100 hasPublicationYear "2023" @default.
• W4367627100 type Work @default.
• W4367627100 citedByCount "0" @default.
• W4367627100 crossrefType "journal-article" @default.
• W4367627100 hasAuthorship W4367627100A5000128145 @default.
• W4367627100 hasAuthorship W4367627100A5010330339 @default.
• W4367627100 hasAuthorship W4367627100A5015296994 @default.
• W4367627100 hasAuthorship W4367627100A5042990707 @default.
• W4367627100 hasAuthorship W4367627100A5072372429 @default.
• W4367627100 hasBestOaLocation W43676271001 @default.
• W4367627100 hasConcept C126322002 @default.
• W4367627100 hasConcept C12823836 @default.
• W4367627100 hasConcept C13373296 @default.
• W4367627100 hasConcept C15490471 @default.
• W4367627100 hasConcept C170493617 @default.
• W4367627100 hasConcept C1862650 @default.
• W4367627100 hasConcept C2776914184 @default.
• W4367627100 hasConcept C2777883359 @default.
• W4367627100 hasConcept C2779245659 @default.
• W4367627100 hasConcept C2779830541 @default.
• W4367627100 hasConcept C2781118164 @default.
• W4367627100 hasConcept C31179232 @default.
• W4367627100 hasConcept C42219234 @default.
• W4367627100 hasConcept C71924100 @default.
• W4367627100 hasConcept C87753298 @default.
• W4367627100 hasConcept C98274493 @default.
• W4367627100 hasConceptScore W4367627100C126322002 @default.
• W4367627100 hasConceptScore W4367627100C12823836 @default.
• W4367627100 hasConceptScore W4367627100C13373296 @default.
• W4367627100 hasConceptScore W4367627100C15490471 @default.
• W4367627100 hasConceptScore W4367627100C170493617 @default.
• W4367627100 hasConceptScore W4367627100C1862650 @default.
• W4367627100 hasConceptScore W4367627100C2776914184 @default.
• W4367627100 hasConceptScore W4367627100C2777883359 @default.
• W4367627100 hasConceptScore W4367627100C2779245659 @default.
• W4367627100 hasConceptScore W4367627100C2779830541 @default.
• W4367627100 hasConceptScore W4367627100C2781118164 @default.
• W4367627100 hasConceptScore W4367627100C31179232 @default.
• W4367627100 hasConceptScore W4367627100C42219234 @default.
• W4367627100 hasConceptScore W4367627100C71924100 @default.
• W4367627100 hasConceptScore W4367627100C87753298 @default.
• W4367627100 hasConceptScore W4367627100C98274493 @default.
• W4367627100 hasIssue "5" @default.
• W4367627100 hasLocation W43676271001 @default.
• W4367627100 hasLocation W43676271002 @default.
• W4367627100 hasLocation W43676271003 @default.
• W4367627100 hasOpenAccess W4367627100 @default.
• W4367627100 hasPrimaryLocation W43676271001 @default.

• next